These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10783812)

  • 1. Estimating risk difference in multicenter studies under baseline-risk heterogeneity.
    Böhning D; Sarol J
    Biometrics; 2000 Mar; 56(1):304-8. PubMed ID: 10783812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantel-Haenszel-type inference for cumulative odds ratios with a stratified ordinal response.
    Liu IM; Agresti A
    Biometrics; 1996 Dec; 52(4):1223-34. PubMed ID: 8962452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A random effects model for multivariate failure time data from multicenter clinical trials.
    Cai J; Sen PK; Zhou H
    Biometrics; 1999 Mar; 55(1):182-9. PubMed ID: 11318153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator.
    Böhning D; Malzahn U; Dietz E; Schlattmann P; Viwatwongkasem C; Biggeri A
    Biostatistics; 2002 Dec; 3(4):445-57. PubMed ID: 12933591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two methods of estimating a common risk difference in a stratified analysis of a multicenter clinical trial.
    O'Gorman TW; Woolson RF; Jones MP
    Control Clin Trials; 1994 Apr; 15(2):135-53. PubMed ID: 8205804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratified experiments reexamined with emphasis on multicenter trials.
    Ganju J; Mehrotra DV
    Control Clin Trials; 2003 Apr; 24(2):167-81. PubMed ID: 12689738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A covariance estimator for GEE with improved small-sample properties.
    Mancl LA; DeRouen TA
    Biometrics; 2001 Mar; 57(1):126-34. PubMed ID: 11252587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.
    Kahan BC; Harhay MO
    J Clin Epidemiol; 2015 Dec; 68(12):1504-11. PubMed ID: 25985892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient treatment allocation in 2 × 2 multicenter trials when costs and variances are heterogeneous.
    Lemme F; van Breukelen GJP; Candel MJJM
    Stat Med; 2018 Jan; 37(1):12-27. PubMed ID: 28948651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the combined response to treatment in multicenter trials.
    Dragalin V; Fedorov V; Jones B; Rockhold F
    J Biopharm Stat; 2001 Nov; 11(4):275-95. PubMed ID: 12018780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for pooling results from multi-center studies.
    Worthington H
    J Dent Res; 2004; 83 Spec No C():C119-21. PubMed ID: 15286137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing bivariate repeated measures for discrete and continuous outcome variables.
    Rochon J
    Biometrics; 1996 Jun; 52(2):740-50. PubMed ID: 8672710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial.
    Legrand C; Duchateau L; Sylvester R; Janssen P; van der Hage JA; van de Velde CJ; Therasse P
    Clin Trials; 2006; 3(1):10-8. PubMed ID: 16539086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the treatment difference in multicenter trials.
    Fedorov V; Jones B; Jones M; Zhigljavsky A
    J Biopharm Stat; 2004 Nov; 14(4):1037-63. PubMed ID: 15587979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust analysis of a mixed-effect model for a multicenter clinical trial.
    Patel HI
    J Biopharm Stat; 2002 Feb; 12(1):21-37. PubMed ID: 12146718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.